Clinic Safe Solutions exists because the gap between a promising bench result and a safe product is the Achilles heel of most life science start-ups, costing them the most time and money.
Founded in Singapore, Clinic Safe Solutions was built around a simple observation: start-ups rarely fail because their science doesn't work. They stall because the road from bench-scale to a production batch involves scale-up, process changes, and quality and biosafety testing that don't meet the mark.
We take these out of the equation — coordinating the testing and regulatory work involved, so you can focus on optimizing the process and product attributes that are actually yours to control, and that matter to building an effective product.
A batch that can't be defended in an audit isn't finished. Every run is recorded to a standard that holds up under regulatory review, not just internal sign-off.
Bench-scale work is planned against your GMP target from the outset, so scale-up doesn't mean starting the science over.
The scientists who develop your process are accountable for the batch that comes out of it — no hand-off, no re-explaining context.
If a milestone isn't realistic, we say so early — a delayed truth costs a start-up far more than an uncomfortable one.
Whether you're at the flask stage or preparing a tech transfer, we'll give you a straight read on what's next.
Get in touch